Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

96 results about "Protein Renaturation" patented technology

The reconstitution of a protein's activity following denaturation.

Metal chelating nano medium, preparation method and method applied to strengthen inclusion body protein renaturation and integrated purification

The invention relates to a metal chelating nano medium, a preparation method and a method applied to strengthen inclusion body protein renaturation and integrated purification, wherein connection polymers P (GMA-IDA) of iminodiacetic acid and glycidyl methacrylate are grafted on the surfaces of silicon dioxide nanoparticles which are 20-30nm in mean grain sizes, and the electric density of medium is 2520-5680Mu mol/g. Extremely high electric density enhances electrostatic repulsion between the medium and homocharge protein molecules, thereby more effectively restraining gathering of proteins. A large number of metal chelating groups which are arranged on the surface of the nano medium guarantee recombinant target proteins which are marked through poly-L-histidine to be effectively adsorbed and separated after completing renaturation. The metal chelating nano medium, the preparation method and the method applied to strengthen inclusion body protein renaturation and integrated purification do not need expensive large equipment such as chromatographic columns or chromatographic systems and the like, complete integration of inclusion body protein renaturation and purification outside the chromatographic columns, are simple, convenient and easy to operate and low in cost, simplify refinement and purification method, and are more suitable for large scale industrialization production.
Owner:TIANJIN UNIV

Freeze-dried protein renaturation method

InactiveCN101565448AAvoid damageReduce molecular thermal motionPeptide preparation methodsSolubilityFreeze-drying
The invention relates to a freeze-dried protein renaturation method based on a natural phenomenon that solute is naturally separated from solvent in the solution freezing process. The solubility of solute salt in a solution is influenced by temperature, denaturation salt (urea, guanidine hydrochloride, and the like) is gradually crystallized and separated from the solution because the solubility of the denaturation salt lowers at a low temperature, and two vital denaturation factors, namely molecular heat movement and the denaturation salt concentration of the solution, are reduced. The crystallization speed can be controlled by the temperature drop speed so as to establish a wonderful condition for protein renaturation, namely the low temperature as well as a smooth downward gradient of the denaturation salt concentration. Meanwhile, a renaturation solution is aided with antifreezing agents (DMSO, fucose, glucose, and the like) with a certain concentration, renaturation activators (cyclodextrin, glycin, molecular chaperones, and the like), reductant-oxidant, buffer salts, and the like for preventing freezing damage to the protein activity and improving the renaturation rate. The frozen dry protein is dried by a freeze drier to obtain solid particles which are suitably vibrated to break by utilizing the difference between the denaturation salt and dry protein powder in the crystallization proportion and the crystallization form and separated by adopting the methods of pneumatic separation, sieving, electrostatic adherence and the like to obtain target protein.
Owner:张鹏

Sika deer IGF (Insulin-like Growth Factor)-1 polypeptide and preparation method thereof

The invention discloses a gene of sika deer IGF (Insulin-like Growth Factor)-1 mature peptide. An EcoR I restriction enzyme cutting site and a base sequence of code Asn are added at the end 5 of a forward primer; a Hind III restriction enzyme cutting site and a sequence of a termination codon are added at the end 5 of a reverse primer; a base sequence 234bp gene for expressing the sika deer IGF-1 mature peptide is cloned; an expression vector, namely pET-32a-IGF-1 is constructed and is induced and expressed in Escherichia coli Rosetta to obtain the sika deer IGF-1 mature peptide. The EcoR I restriction enzyme cutting site and the Hind III restriction enzyme cutting site are introduced and an Asn is added in front of natural IGF-1, so that a specific cracking part of hydroxylamine is formed, and further the cutting cost of protein is reduced, the influence on protein renaturation caused by extra amino acid sequence is reduced and the state of the protein in a natural state is kept. The pET-32a as an expression vector is expressed in the Escherichia coli Rosetta, so that the protein content can reach over 50 percent of soluble protein of thallus; and through the detection by adopting an MTT (Methyl Thiazolyl Tetrazolium) method, the multiplication rate of N1H3T3 cells can be increased.
Owner:JILIN AGRICULTURAL UNIV

Method for purifying recombinant VP1 antigen of enterovirus type 71 viruses

The invention relates to a method for purifying a recombinant protein of the gene engineering and aims to provide a method for purifying a recombinant VP1 antigen of enterovirus type 71 viruses. The method comprises the following steps of: expressing and producing a recombinant VP1 protein of the enterovirus type 71 viruses by Escherichia coli obtain an inclusion body of the protein; dissolving the inclusion body in solubilizing liquid; and dropwise adding the solution of the inclusion body into renaturation solution under the conditions of water bath and magnetic stirring and then carrying out stirring renaturation on the mixture for 48 hours. The invention discloses the method, which can make the protein existing in a form of the inclusion body become a soluble protein by protein renaturation so as to greatly improve recovery rate of an expression product. The method adopts affinity chromatography for purification in one step. The purity is over 95 percent. The method for purifying the recombinant VP1 antigen of the enterovirus type 71 viruses has simple, convenient and time-saving operation, is favorable for large-scale industrial production, has the advantages of low cost, simple and convenient process, high purity of the purified protein and the like and can provide the diagnostic antigen for development of an EV type 71 diagnostic reagent and seroepidemiological survey.
Owner:HANGZHOU ZHEDA ZIJIN BIOTECH

Method for assisting lysozyme renaturation in vitro by granular poly(N-isopropylacrylicamide-sodium acrylate) copolymer hydrogel

InactiveCN101363018AInhibit aggregation tendencyHigh activityEnzymesProtein targetSwelling ratio
The invention discloses a method for assisting the in vitro renaturation of lysozyme by using granular poly (N-isopropylacrylamide-sodium acrylate) copolymer gel, the specific steps are as follows: 1) the granular poly (N-isopropylacrylamide-sodium acrylate) copolymer gel is prepared by using the inverse suspension copolymerization; 2) the granular poly (N-isopropylacrylamide-sodium acrylate) copolymer gel is used for assisting the in vitro renaturation of the lysozyme. The granular poly (N-isopropylacrylamide-sodium acrylate) copolymer gel which is developed by the method is taken as a novel protein in vitro renaturation additive, thereby having the following advantages: (1) the activity recovery rate of a target protein can be significantly improved under the condition of high denatured protein concentration; (2) the separation and the recovery are convenient by utilizing the thermosensitive characteristic of the gel after the completion of the renaturation, and the gel can be repeatedly utilized; (3) the hydrophobic performance of the gel can be regulated by controlling the content of the co-monomer sodium acrylate, thereby changing the low critical dissolution temperature and the largest swelling ratio and being applicable to the different target proteins. Therefore, the gel has better application prospect in the field of the protein renaturation.
Owner:ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products